Vaccines Against Mycoplasma
Maruyama vaccine is similar to BCG vaccine, both of which are made from mycobacteria tuberculosis isolates. Murayama vaccine is made from mycobacteria tuberculosis isolates, and BCG is derived from an attenuated bovine tuberculosis bacillus. Maruyama vaccine, invented by Dr. Chisato Maruyama more than 50 years ago, can be used by itself or in combination with standard therapies. You can find medications at affordable prices in our online pharmacy. Murayama vaccine is approved by the FDA to treat terminal cancer patients.
Some forms of health insurance will cover the cost if the vaccine is used as part of standard therapy, because it is officially approved only as an immune system stimulant to counteract the side effect of bone marrow suppression caused by radiotherapy. Mycoplasmal infections are treatable with long cycles of high-dose antibiotics such as doxycycline and tetracycline, followed by a long period of low dose antibiotics. Maruyama vaccine is supplied by The Research Institute of Vaccine Therapy for Tumors and Infections Disease, Nippon Medical School Hospital in Tokyo, as long as the patient supplies a request from their physician. According to an article published in Cancer Detection And Prevention, 2003, by Tetsuo Kimoto M.D., Ph.D., Maruyama vaccine does not have direct cytotoxic effects on tumors, but rather causes their encapsulation by collagen fibers.
This leads to the containment and sometimes necrosis of tumors and their metastasis. Survival time increased in both animal and human subjects with tumors, and Kimoto stated that Murayama vaccine may benefit patients in whom the tumor is inoperable and resistant to conventional chemotherapy. Cervical cancer, caused by the human papilloma virus, strikes more than 10,000 USA women every year, killing more than 3,700. A new vaccine against the virus, Gardasil, was approved by the FDA in 2006. The vaccine is effective against HPV types 16 and 18, which cause about 70% of cervical cancers and against HPV types 6 and 11, which cause approximately 90% of genital warts.
|